Molecular Docking: Applications and Its Challenges

H L Kulkarni

Abstract


Molecular Docking is the computational modeling of the structure of complexes formed by two or more interrelating molecules. The aim of molecular docking is the prediction of the three-dimensional structures of importance. Molecular docking is a kind of bioinformatic modeling which includes the interaction of two or more molecules to give the constant adduct. Depending upon binding properties of ligand and target, it predicts the three-dimensional structure of any complex. Molecular docking produces various possible adduct structures that are ranked and grouped together using scoring function in the software. In spite of all possible approaches, ligand chemistry (tautomerism and ionization), receptor flexibility (single conformation of rigid receptor) and scoring function (differentiate true binding mode) still persisted the challenge. The vital aspects of molecular docking in its applications and challenges are briefly discussed in this article.

Full Text:

PDF

References


Rohs R, Bloch I, Sklenar H, Shakked Z (2005) Molecular flexibility in ab-initio drug docking to DNA: binding-site and binding-mode transitions in all-atom Monte Carlo simulations. Nucl Acids Res 33: 7048-7057.

Guedes IA, de Magalhães CS, Dardenne LE (2014) Receptor-ligand molecular docking. Biophysical Reviews 6: 75-87.

Agarwal S, Chadha D, Mehrotra R (2015) Molecular modeling and spectroscopic studies of semustine binding with DNA and its comparison with lomustine–DNA adduct formation. J Biomol Struct Dyn 33: 1653-1668.

Seeliger D, de Groot BL (2010) Ligand docking and binding site analysis with PyMOL and Autodock/Vina. J Comput Aided Mol Des 24: 417-422.

Shoichet BK, McGovern SL, Wei B, Irwin JJ (2002) Lead discovery using molecular docking. Curr Opin Chem Biol 6: 439-446.

Lamb ML, Jorgensen WL (1997) Computational approaches to molecular recognition. Curr Opin Chem Biol 1: 449-457.

Gschwend DA, Good AC, Kuntz ID (1996) Molecular docking towards drug discovery. J Mol Recognit 9: 175-186.

Ferreira LG, dos Santos RN, Oliva G, Andricopulo AD (2015) Molecular docking and structure-based drug design strategies. Molecules 20: 13384-13421.

Agarwal S, Jangir DK, Mehrotra R, Lohani N, Rajeswari M (2014) A Structural insight into major groove directed binding of nitrosourea derivative nimustine with DNA: a spectroscopic study. PLoS One 9: 104-115.

Mehrotra R, Jangir DK, Agarwal S, Ray B, Singh P, et al. (2013) Interaction studies of anticancer drug lomustine with calf thymus DNA using surface enhanced Raman spectroscopy. MAPAN 28: 273-277.


Refbacks

  • There are currently no refbacks.